Status:

RECRUITING

Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health

Lead Sponsor:

Columbia University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Sedentary Behavior

Cardiometabolic Risk Factors

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this Phase 1 research study is to answer two questions: (1) How frequent should periods of prolonged sedentary time be interrupted? and (2) What is the appropriate duration or length of...

Detailed Description

Excessive sedentary behavior is highly prevalent in developed nations and is a risk factor for cardiovascular disease (CVD) morbidity and mortality. Evidence suggests sedentary behavior is not simply ...

Eligibility Criteria

Inclusion

  • 18 years of age or older
  • Ability to read, write and speak English or Spanish
  • Limited or no chronic medical conditions \[examples include but not limited to: CVD, diabetes, chronic obstructive pulmonary disease (COPD), HIV/AIDS; participants with high blood pressure/hypertension and/or high cholesterol/hyperlipidemia may be included if they are currently prescribed and taking medication for these conditions\]
  • Do not take medication (over-the-counter or herbal) to control glucose (such as a diabetes control medication)
  • Not currently pregnant
  • Do not currently smoke cigarettes
  • No pre-existing musculoskeletal conditions (including but not limited to osteoarthritis, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis) that would prevent participation in intermittent physical activity
  • No allergies to common food allergens including wheat, eggs, milk or other dairy, gluten, fructose, peanuts or other nuts
  • No dietary restrictions such as vegan, gluten free, halal

Exclusion

  • • Unable to provide consent

Key Trial Info

Start Date :

June 30 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2026

Estimated Enrollment :

324 Patients enrolled

Trial Details

Trial ID

NCT05353322

Start Date

June 30 2022

End Date

March 31 2026

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center for Behavioral Cardiovascular Health

New York, New York, United States, 10032